PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
HumanaMedicare Advantage · Coverage · Medicare Advantage · IA, KS, MO, NE, IN, MI, KY, OH, CA, HI, NV, AS, GU, MP, AK, AZ, ID, MT, ND, OR, SD, UT, WA, WY, AL, GA, TN, NC, SC, VA, WV · Gastroenterology, Internal Medicine, Infectious DiseaseMedium impact

Noninvasive Tests for Hepatic Fibrosis - Medicare Advantage (Revised)

Effective date
Oct 1, 2026
Identified
Oct 2, 2026

Summary

This is a Medicare Advantage policy update (effective 10/01/2026) covering noninvasive tests for hepatic fibrosis, including imaging-based tests (MRE, qMRA) and blood-based biomarker panels (ELF, FIB-4, FibroSure, LiverFASt, NIS4, OWLiver, TruD, HepQuantDuO). The policy establishes coverage determination criteria for these tests across multiple MAC jurisdictions. The document provided is incomplete and does not contain the full coverage determination criteria, medical necessity requirements, or specific billing code guidance needed for implementation.

Get alerts when payers change rules like this one

We check Humana and other payers every day and email you when a change matches your specialty and state.

Get Humana alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01REQUIREMENTS: - By September 8, 2026 (policy review date): Billing and clinical teams must obtain the complete policy document (document appears truncated) to identify all coverage criteria, medical necessity requirements, prior authorization rules, and applicable billing codes for hepatic fibrosis noninvasive tests.
02- Before October 1, 2026 (effective date): Update billing system rules and prior authorization workflows to reflect coverage requirements for noninvasive hepatic fibrosis tests across applicable MAC jurisdictions (J5, J8, J15, JE, JF, JJ, JM).
03- Gastroenterology and hepatology providers must update encounter forms and documentation templates to capture required clinical criteria for medical necessity determinations.
04- Verify which MAC jurisdiction applies to your practice location and implement jurisdiction-specific coverage rules.
05- Contact Humana directly to obtain the complete policy text beyond page 5, as the provided document ends mid-sentence in the Coverage Determination section.

Original notice

Noninvasive Tests for Hepatic Fibrosis - Medicare Advantage (Revised)
mcp.humana.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account